About Enhancer
| Enhancer ID: | E_01_1014 |
| Species: | human |
| Position : | chr16:18801868-18803868   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | heart disease |
| Pubmed ID: | 30922078 |
| Enhancer experiment: | Immunohistochemistry, gel electrophoresis, qPCR |
| Enhancer experiment description: | Consequently, a substrate of SMG1, ATP-dependent RNA helicase upframeshift 1, is hyperphoshorylated in a HERNA1- and SMG1-dependent manner. |
About Target gene
| Target gene : | SMG1 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Consequently, a substrate of SMG1, ATP-dependent RNA helicase upframeshift 1, is hyperphoshorylated in a HERNA1- and SMG1-dependent manner. |
About TF
| TF name : | -- |
| TF experiment: | ?????????? qPCR |
| TF experiment description: | Consequently, a substrate of SMG1, ATP-dependent RNA helicase upframeshift 1, is hyperphoshorylated in a HERNA1- and SMG1-dependent manner. |
About Function
| Enhancer function : | Consequently, a substrate of SMG1, ATP-dependent RNA helicase upframeshift 1, is hyperphoshorylated in a HERNA1- and SMG1-dependent manner. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Consequently, a substrate of SMG1, ATP-dependent RNA helicase upframeshift 1, is hyperphoshorylated in a HERNA1- and SMG1-dependent manner. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene